UNCOVERED: 14 - The Untold Story

Exciting new drug is ‘beginning of the end’ for Alzheimer’s – so what is it and when could it be available?

As trial results bring hope of an effective treatment, Lisa Salmon asks The Alzheimer’s Society what it means for people right now.

The Independent UK · Nov 30, 2022

Drug proven to slow decline in Alzheimer patients

Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients

Manchester Evening News · Nov 30, 2022

‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

The New Daily · Nov 30, 2022

New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment

Clinical results suggest that the disease progression can by slowed by 27%

Wales Online · Nov 30, 2022

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Lecanemab was found to slow decline in patients’ memory and thinking.

The Independent UK · Nov 30, 2022

Another Alzheimer’s drug fails in late-stage trials – what now?

Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab.

The Conversation · Nov 22, 2022

How likely is Chris Hemsworth to get Alzheimer’s disease and what are its signs?

The actor told Vanity Fair the discovery he is at high risk is his ‘biggest fear’ but said: ‘It’s not like I’ve been handed my resignation’

Evening Standard · Nov 22, 2022

Chris Hemsworth reveals he inherits Alzheimer's gene from both parents. What is the ApoE4 gene and what does it mean for his career?

After two decades of acting, Chris Hemsworth revealed he will take a break from his career, after learning he has a much higher-than-average chance of developing Alzheimer's disease.

ABC News · Nov 21, 2022

Chris Hemsworth learns he has a predisposition to Alzheimer's disease; may take break from acting

Hollywood actor Chris Hemsworth, who recently featured in the docuseries 'Limitless', has revealed that he has a genetic predisposition to Alzheimer's disease, and therefore may be taking a break from acting.

The Times of India · Nov 20, 2022

My work investigating the links between viruses and Alzheimer’s disease was dismissed for years – but now the evidence is building

This article is part of the Insights Uncharted Brain series. There are many competing theories about what causes Alzheimer’s disease. Here, Ruth Itzhaki reflects on a career dedicated to one of the more controversial lines of research.

The Conversation · Nov 15, 2022